Vinorelbine With Capecitabine, an Evergreen Doublet for Advanced Breast Cancer: A Systematic Literature Review and Pooled-Analysis of Phase II-III Studies

Fausto Petrelli; Serena Di Cosimo; Veronica Lonati; Sandro Barni

doi:10.1016/j.clbc.2016.05.002

Vinorelbine With Capecitabine, an Evergreen Doublet for Advanced Breast Cancer: A Systematic Literature Review and Pooled-Analysis of Phase II-III Studies

Clinical Breast Cancer ◽

10.1016/j.clbc.2016.05.002 ◽

2016 ◽

Vol 16 (5) ◽

pp. 327-334 ◽

Cited By ~ 7

Author(s):

Fausto Petrelli ◽

Serena Di Cosimo ◽

Veronica Lonati ◽

Sandro Barni

Keyword(s):

Breast Cancer ◽

Literature Review ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Systematic Literature Review ◽

Pooled Analysis ◽

Advanced Breast

Download Full-text

Systematic Literature Review of the Impact of Endocrine Monotherapy and in Combination with Targeted Therapy on Quality of Life of Postmenopausal Women with HR+/HER2− Advanced Breast Cancer

Advances in Therapy ◽

10.1007/s12325-017-0644-2 ◽

2017 ◽

Vol 34 (12) ◽

pp. 2566-2584 ◽

Cited By ~ 2

Author(s):

Zhou Zhou ◽

Derek H. Tang ◽

Jipan Xie ◽

Rajeev Ayyagari ◽

Eric Wu ◽

...

Keyword(s):

Breast Cancer ◽

Quality Of Life ◽

Targeted Therapy ◽

Literature Review ◽

Advanced Breast Cancer ◽

Postmenopausal Women ◽

Systematic Literature Review ◽

Advanced Breast ◽

The Impact

Download Full-text

Abstract P3-08-40: Prognostic factors associated with clinical outcomes in HR+, HER2- advanced breast cancer: Systematic literature review

10.1158/1538-7445.sabcs19-p3-08-40 ◽

2020 ◽

Author(s):

Gebra C Carter ◽

Keri Stenger ◽

Maitreyee Mohanty ◽

Amy L Chong ◽

Pradeep Basa ◽

...

Keyword(s):

Breast Cancer ◽

Prognostic Factors ◽

Literature Review ◽

Advanced Breast Cancer ◽

Clinical Outcomes ◽

Systematic Literature Review ◽

Advanced Breast ◽

Factors Associated

Download Full-text

Correction to: Efficacy and safety of fulvestrant in postmenopausal patients with hormone receptor-positive advanced breast cancer: a systematic literature review and meta-analysis

Breast Cancer Research and Treatment ◽

10.1007/s10549-018-5047-9 ◽

2018 ◽

Vol 173 (2) ◽

pp. 487-487

Author(s):

Jiayu Wang ◽

Binghe Xu ◽

Wenna Wang ◽

Xiaoyu Zhai ◽

Xuelian Chen

Keyword(s):

Breast Cancer ◽

Literature Review ◽

Advanced Breast Cancer ◽

Systematic Literature Review ◽

Hormone Receptor ◽

Meta Analysis ◽

Advanced Breast ◽

Efficacy And Safety ◽

Hormone Receptor Positive

Download Full-text

Efficacy and safety of fulvestrant in postmenopausal patients with hormone receptor-positive advanced breast cancer: a systematic literature review and meta-analysis

Breast Cancer Research and Treatment ◽

10.1007/s10549-018-4867-y ◽

2018 ◽

Vol 171 (3) ◽

pp. 535-544 ◽

Cited By ~ 5

Author(s):

Jiayu Wang ◽

Binghe Xu ◽

Wenna Wang ◽

Xiaoyu Zhai ◽

Xuelian Chen

Keyword(s):

Breast Cancer ◽

Literature Review ◽

Advanced Breast Cancer ◽

Systematic Literature Review ◽

Hormone Receptor ◽

Meta Analysis ◽

Advanced Breast ◽

Efficacy And Safety ◽

Hormone Receptor Positive

Download Full-text

Ethical issues in autologous stem cell transplantation (ASCT) in advanced breast cancer: A systematic literature review

BMC Medical Ethics ◽

10.1186/1472-6939-12-6 ◽

2011 ◽

Vol 12 (1) ◽

Cited By ~ 7

Author(s):

Sigrid Droste ◽

Annegret Herrmann-Frank ◽

Fueloep Scheibler ◽

Tanja Krones

Keyword(s):

Breast Cancer ◽

Stem Cell ◽

Literature Review ◽

Stem Cell Transplantation ◽

Advanced Breast Cancer ◽

Cell Transplantation ◽

Autologous Stem Cell Transplantation ◽

Systematic Literature Review ◽

Ethical Issues ◽

Advanced Breast

Download Full-text

Phase II Clinical Study of Pyrotinib Combined With Etoposide to Treat HER2-positive Advanced Breast Cancer

Case Medical Research ◽

10.31525/ct1-nct03923179 ◽

2019 ◽

Author(s):

Keyword(s):

Breast Cancer ◽

Clinical Study ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Advanced Breast ◽

Her2 Positive ◽

Phase Ii Clinical Study

Download Full-text

PALINA: A phase II safety study of palbociclib in combination with letrozole or fulvestrant in African American women with hormone receptor positive HER2 negative advanced breast cancer

Contemporary Clinical Trials Communications ◽

10.1016/j.conctc.2018.05.012 ◽

2018 ◽

Vol 10 ◽

pp. 190-192

Author(s):

Filipa Lynce ◽

Mervat Saleh ◽

Ayesha Shajahan-Haq ◽

Christopher Gallagher ◽

Asma Dilawari ◽

...

Keyword(s):

Breast Cancer ◽

African American ◽

Advanced Breast Cancer ◽

African American Women ◽

Phase Ii ◽

Hormone Receptor ◽

Advanced Breast ◽

Safety Study ◽

American Women ◽

Hormone Receptor Positive

Download Full-text

346 Taxol or doxorubicin as first line chemotherapy in advanced breast cancer (ABC). A prospective randomized phase II study with crossover

European Journal of Cancer ◽

10.1016/0959-8049(95)95599-2 ◽

1995 ◽

Vol 31 ◽

pp. S75 ◽

Cited By ~ 1

Author(s):

R. Paridaens ◽

P. Bruning ◽

F. Calabresi ◽

A. Awada ◽

J.A. Roy ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Advanced Breast ◽

First Line ◽

Randomized Phase Ii ◽

Line Chemotherapy

Download Full-text

Megestrol acetate: Phase II study of a single daily administration in advanced breast cancer

Breast Cancer Research and Treatment ◽

10.1007/bf01812684 ◽

1990 ◽

Vol 17 (1) ◽

pp. 51-54 ◽

Cited By ~ 9

Author(s):

Paolo Pronzato ◽

Fulvio Brema ◽

Domenico Amoroso ◽

Gianfilippo Bertelli ◽

Pier Franco Conte ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Advanced Breast ◽

Megestrol Acetate ◽

Daily Administration

Download Full-text

Phase II trial of pegylated liposomal doxorubicin (Caelyx™) plus Gemcitabine in chemotherapeutically pretreated patients with advanced breast cancer

Acta Oncologica ◽

10.1080/02841860600897868 ◽

2007 ◽

Vol 46 (2) ◽

pp. 208-213 ◽

Cited By ~ 7

Author(s):

Herbert Ulrich-Pur ◽

Gabriela V. Kornek ◽

Karin Haider ◽

Werner Kwasny ◽

Thomas Payrits ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Liposomal Doxorubicin ◽

Phase Ii Trial ◽

Pegylated Liposomal Doxorubicin ◽

Advanced Breast ◽

Pretreated Patients

Download Full-text